Zentek Ltd.

NASDAQ:ZTEK

Other Precious Metals

Basic Materials
$0.49 +25.56%

+$0.10 today

Market cap
$62.30M
Beta
0.47
P/E (TTM)
-9.6
EPS (TTM)
-$0.08
52W Low $0.37High $1.34

Volume 0.93M

Average 0.15M

ZTEK Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

Zentek Ltd.NASDAQ: ZTEK

Depreciation & Amortization · Q4 FY2025 · quarter ended Mar 2026

Depreciation & amortization dips below year-ago levels

Q4 FY2025 depreciation & amortization of CA$127.18K fell 8.9% year over year, behind the +1.5% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 2.2% from the prior quarter. Over 3 fiscal years it compounded at -0.7% a year.

Context

  • Depreciation & amortization amounted to 317.0% of revenue in FY2025, up 248.2 pp from a year earlier.
  • Depreciation & amortization increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -8.9% toward the trailing-twelve-month pace of +1.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$127.18K-2.2% QoQ
Last fiscal yearMar 2026
CA$527.77K-12.1% YoY
LTMMar 2026
CA$526.63K+1.5% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-8.9%——
1 year-12.1%——
3-year CAGR-0.7%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

CAD · from the cash flow

Latest · FY2025
527.77K CAD
Year-over-year change
-12.1%
4-year CAGR
-3.7%

Depreciation & Amortization vs competitors

How ZTEK compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +1.5% is the 5th highest of 9, against a peer median of -10.3%.
  • Depreciation & amortization amounts to 317.1% of revenue for ZTEK, versus a peer median of 13.5%.
ZTEK Competitors
Depreciation & Amortization for ZTEK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMWLAmerican Well CorporationLTM Mar 2026$34.69M USD+5.2%+9.1%14.6%
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$2.28M CAD-57.9%+10.7%12.4%
HYPRHyperfine, Inc.LTM Mar 2026$1.38M USD+41.1%+2.4%9.0%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$1.12M USD+22.5%+35.7%—
ALXOALX Oncology Holdings Inc.LTM Mar 2026$645K USD-25.8%+27.3%—
ZTEKZentek Ltd.LTM Mar 2026CA$526.63K CAD+1.5%-0.7%317.1%
BYSIBeyondSpring Inc.LTM Mar 2026$144K USD+80.0%-27.9%—
CRDLCardiol Therapeutics Inc.LTM Mar 2026CA$103.77K CAD-69.2%-22.6%—
MBOTMicrobot Medical Inc.LTM Mar 2026$44K USD-43.6%-22.8%41.9%
Peer median (excluding ZTEK) —-10.3%+5.7%13.5%

Competitors are the stored peer set for ZTEK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Net Income(12.02M)(14.41M)(8.64M)(10.04M)(9.79M)
Depreciation & Amortization614.71K539.69K453.04K600.32K527.77K
Deferred Income Tax0(808.08K)000
Stock-Based Compensation4.73M3.2M01.53M0
Change in Working Capital(1.36M)(2.4M)675.37K1.48M1.5M
Accounts Receivables(536.82K)(12.84K)201.14K(906.22K)833.64K
Inventory(665.57K)(2.18M)(51.86K)397.48K168.74K
Accounts Payables831.48K000406.52K
Other Working Capital(985.52K)(198.98K)526.09K1.98M92.57K
Other Non-Cash Items48.12K917.7K1.57M150.99K2.68M
Operating Cash Flow(7.99M)(12.96M)(5.94M)(6.28M)(5.08M)
Capital Expenditures(3.99M)(2.27M)(236.3K)(1.4K)(2.03K)
Acquisitions (Net)007.38K02.38M
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(3.27M)(33.64K)1.82M360.05K0
Investing Cash Flow(7.25M)(2.31M)1.39M358.65K1.67M
Debt Repayment(122.45K)(1.1M)(177.43K)(562.11K)1.63M
Common Stock Issued35.34M083.42K3.07M3.13M
Common Stock Repurchased00(301.82K)00
Dividends Paid00000
Other Financing Activities3.6M46K(95.42K)16.01K(172.43K)
Financing Cash Flow38.82M(1.05M)(491.25K)2.52M4.59M
Effect of Forex Changes005.31M04.08K
Net Change in Cash23.58M(16.32M)268.59K(3.4M)1.19M
Free Cash Flow(11.97M)(15.23M)(6.18M)(6.28M)(5.08M)

Zentek Ltd.

NASDAQ:ZTEK

Intrinsic Alpha fair value

Locked

Current Price

$0.49

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.